Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea

Details for Australian Patent Application No. 2003220119 (hide)

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 60/363,053 07.03.02 US; 60/363,054 07.03.02 US; 60/416,983 07.10.02 US; 60/363,341 07.03.02 US

30 October 2003 Application Open to Public Inspection

Published as AU-A-2003220119

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.